[go: up one dir, main page]

IL313009B1 - Collagen 1 translation inhibitors and methods of use thereof - Google Patents

Collagen 1 translation inhibitors and methods of use thereof

Info

Publication number
IL313009B1
IL313009B1 IL313009A IL31300924A IL313009B1 IL 313009 B1 IL313009 B1 IL 313009B1 IL 313009 A IL313009 A IL 313009A IL 31300924 A IL31300924 A IL 31300924A IL 313009 B1 IL313009 B1 IL 313009B1
Authority
IL
Israel
Prior art keywords
collagen
methods
translation inhibitors
inhibitors
translation
Prior art date
Application number
IL313009A
Other languages
Hebrew (he)
Other versions
IL313009A (en
Original Assignee
Anima Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anima Biotech Inc filed Critical Anima Biotech Inc
Priority to IL313009A priority Critical patent/IL313009B1/en
Priority to PCT/US2025/030095 priority patent/WO2025245046A1/en
Publication of IL313009A publication Critical patent/IL313009A/en
Publication of IL313009B1 publication Critical patent/IL313009B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/423Oxazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL313009A 2024-05-21 2024-05-21 Collagen 1 translation inhibitors and methods of use thereof IL313009B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL313009A IL313009B1 (en) 2024-05-21 2024-05-21 Collagen 1 translation inhibitors and methods of use thereof
PCT/US2025/030095 WO2025245046A1 (en) 2024-05-21 2025-05-20 Collagen 1 translation inhibitors and methods of use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL313009A IL313009B1 (en) 2024-05-21 2024-05-21 Collagen 1 translation inhibitors and methods of use thereof

Publications (2)

Publication Number Publication Date
IL313009A IL313009A (en) 2025-12-01
IL313009B1 true IL313009B1 (en) 2026-01-01

Family

ID=97796035

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313009A IL313009B1 (en) 2024-05-21 2024-05-21 Collagen 1 translation inhibitors and methods of use thereof

Country Status (2)

Country Link
IL (1) IL313009B1 (en)
WO (1) WO2025245046A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021216665A1 (en) * 2020-04-22 2021-10-28 Anima Biotech Inc. Collagen 1 translation inhibitors and methods of use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021216665A1 (en) * 2020-04-22 2021-10-28 Anima Biotech Inc. Collagen 1 translation inhibitors and methods of use thereof

Also Published As

Publication number Publication date
IL313009A (en) 2025-12-01
WO2025245046A1 (en) 2025-11-27

Similar Documents

Publication Publication Date Title
EP4139291A4 (en) Collagen 1 translation inhibitors and methods of use thereof
IL308041A (en) Collagen compositions and methods of use thereof
IL319748A (en) Pcsk9 inhibitors and methods of use thereof
IL313009B1 (en) Collagen 1 translation inhibitors and methods of use thereof
IL310685B2 (en) Collagen 1 translation inhibitors and methods of use thereof
CA3257282A1 (en) Collagen compositions and methods of use thereof
IL314277A (en) Anti-b7-h3 compounds and methods of use
HK40083510A (en) Collagen 1 translation inhibitors and methods of use thereof
HK40083533A (en) Collagen 1 translation inhibitors and methods of use thereof
HK40080159A (en) Collagen 1 translation inhibitors and methods of use thereof
EP4097084A4 (en) COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE
LT4554562T (en) Olanzapine compositions and methods of use
GB202312186D0 (en) Kit of parts and method
GB202406144D0 (en) Composition and method of use
GB202408324D0 (en) Inhibitors of expression and/or function
IL310211A (en) Porcine collagen compositions and methods of use thereof
GB202507080D0 (en) Compositions and method of use relating thereto
GB202416740D0 (en) Anchor apparatus and/or method of use thereof
GB202509578D0 (en) Composition and method of treatment
GB202504281D0 (en) Composition and method of treatment
GB202403805D0 (en) Compositions and methods of treatment
ZA202201808B (en) Preparation method and application of collagen peptide chelated ferrous hydrogel
GB202511967D0 (en) Compositions and methods of using same
GB202313643D0 (en) Serping1-sarna compositions and methods of use
GB202310868D0 (en) compositions and methods of use